Table 2.
Comparison of epigenetic and behavioral abnormalities induced by mGlu2/3 receptors agonist LY379268 and clozapine in PRS mice.
| Clozapine | LY379268 |
|---|---|
| Increase in Gadd45-β expression | Increase in Gadd45-β expression |
| Reduction of the overexpression of DNMT1 and TET1 in frontal cortex | Reduction of the overexpression of DNMT1 and TET1 in frontal cortex |
| Reduction of Gad1, Reln, and Bdnf promoter hypermethylation and increase in their mRNA levels | Reduction of the MeCP2 binding at the mGlu2, Gad1, Bdnf gene promoters |
| Reversal effects of the binding of DNMT1 to unmethylated target promoters | Reversal effects of the binding of MeCP2 to unmethylated target promoters |
| Reduction in locomotor hyperactivity and deficits in SI | Reduction in locomotor hyperactivity and deficits in SI |
BDNF, brain-derived neurotrophic factor; DNMT1, DNA-methyltransferase 1; TET1, ten-eleven methylcytosine dioxygenase 1. Gadd45 (Growth – arrest and DNA damage; MeCP2, Methylcytosine binding protein 2.